4
Changes in Ownership
Gossamer Bio, Inc. Filed Acc 0001728117-22-000011
Options or other derivatives
- Chief Scientific Officer acquired 190,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Carter Laura Chief Scientific Officer | 2022-01-06 | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | D: show line 1 in the form |
Loading xslF345X03/wf-form4_164184919646960.xml…